Logo
A

ABM Therapeutics

10 employees

Bichen Pharmaceutical is a small-molecule tumor-targeted drug developer for the treatment of various malignant tumors and brain metastases.

Basic info

Industry

biotechnology research

Sectors

Pharmaceutical
Biopharma
Medical
Health Care

Date founded

2015

Funding rounds raised

Total raised

$30M

from 4 investors over 4 rounds

A

ABM Therapeutics raised $30M on January 4, 2022

Investors: Sincere Capital, 北京同德金信投资有限公司, Baidu.ventures and PhotonFund

FAQ